| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |